Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06766461
PHASE4
Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis
Sponsor: Erasmus Medical Center
View on ClinicalTrials.gov
Summary
The aim of this study is to investigate if an initial short double dose of beta-lactam antibiotics will reduce mortality in critically ill patients with sepsis.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
980
Start Date
2025-01-03
Completion Date
2027-12-01
Last Updated
2025-01-09
Healthy Volunteers
No
Interventions
DRUG
Double dosing of beta-lactam antibiotic
This arm will receive double dosing of beta-lactam antibiotics for the first 48 hours after inclusion.
Locations (1)
Maasstad Ziekenhuis
Rotterdam, Netherlands